Cargando…
An estrogen analogue and promising anticancer agent refrains from inducing morphological damage and reactive oxygen species generation in erythrocytes, fibrin and platelets: a pilot study
BACKGROUND: 2-Methoxyestradiol is known to have antitumour and antiproliferative action in vitro and in vivo. However, when 2-methoxyestradiol is orally administered, it is rapidly oxidized by the enzyme 17β-hydroxysteriod dehydrogenase in the gastrointestinal tract. Therefore, 2-methoxyestradiol n...
Autores principales: | Repsold, Lisa, Pretorius, Etheresia, Joubert, Annie Margaretha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057810/ https://www.ncbi.nlm.nih.gov/pubmed/24932135 http://dx.doi.org/10.1186/1475-2867-14-48 |
Ejemplares similares
-
Ex vivo apoptotic and autophagic influence of an estradiol analogue on platelets
por: Repsold, Lisa, et al.
Publicado: (2016) -
Eryptosis: An Erythrocyte's Suicidal Type of Cell Death
por: Repsold, Lisa, et al.
Publicado: (2018) -
2-Methoxyestradiol-bis-sulphamate refrains from inducing apoptosis and autophagy in a non-tumorigenic breast cell line
por: Visagie, Michelle H, et al.
Publicado: (2012) -
Platelet Function, Role in Thrombosis, Inflammation, and Consequences in Chronic Myeloproliferative Disorders
por: Repsold, Lisa, et al.
Publicado: (2021) -
Ultrastructural changes of erythrocytes in whole blood after exposure to prospective in silico-designed anticancer agents: a qualitative case study
por: Repsold, Lisa, et al.
Publicado: (2014)